- Stock: In Stock
- Brand: Square Pharmaceuticals
- Product ID: Aripiprazole
100% Secure Payment
Indication:
AriprexTM is indicated for schizophrenia, bipolar disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, agitation associated with schizophrenia or bipolar mania.
Indications
Initial Dose
Recommended Dose
Maximum Dose
Schizophrenia – adults
10-15 mg/day
10-15 mg/day
30 mg/day
Schizophrenia – adolescents (ages 13-17 years)
2 mg/day
10 mg/day
30 mg/day
Bipolar mania – adults: monotherapy
15 mg/day
15 mg/day
30 mg/day
Bipolar mania – adults: adjunct to lithium or valproate
10-15 mg/day
15 mg/day
30 mg/day
Bipolar mania – pediatric patients (ages 10-17 years): monotherapy or as an adjunct to lithium or valproate
2 mg/day
10 mg/day
30 mg/day
As an adjunct to antidepressants for the treatment of major depressive disorder– adults
2-5 mg/day
5-10 mg/day
15 mg/day
Irritability associated with autistic disorder-pediatric patients (ages 6-17 years)
2 mg/day
5-10 mg/day
15 mg/day
• Oral formulations: Administer once daily without regard to meals
Preparation:
AriprexTM 2 Tablet: Box containing 30 tablets in blister pack
AriprexTM 10 Tablet: Box containing 30 tablets in blister pack
AriprexTM 15 Tablet: Box containing 30 tablets in blister pack
AriprexTM Oral Solution: Eack PET bottle contains 50 ml oral solution with measuring cup & dropper
